Viridian Therapeutics, Inc./DE
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $490.4M
Liabilities Breakdown FY2023
Total Liabilities: $48.4M
Asset Breakdown
Total Assets: $490.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $102.8M | 21.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.7M | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $385.9M | 78.7% |
Liabilities Breakdown
Total Liabilities: $48.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.2M | 4.6% |
| Long-Term Debt | $20.2M | 41.7% |
| Other Liabilities | $26.0M | 53.6% |